Increasing prevalence of chronic diseases and digestive enzyme disorders, rapid technological advancements, and rising demand for effective therapeutics are some factors expected to drive global Specialty Enzymes market growth.
Increasing prevalence of chronic diseases and digestive enzyme disorders, rapid technological advancements, and rising demand for effective therapeutics are some factors expected to drive global Specialty Enzymes market growth.
According to Emergen Research, the global specialty enzymes market size was USD 4,565 million in 2021 and is expected to reach USD 8,392.7 million in 2030 and register a steady CAGR of 7.0% during the forecast period, 2022-2030.
Market Dynamics:
Specialty enzymes are proteins that act as biocatalysts in various diagnostic procedures and biocatalysts for speeding up reactions and generating the desired outcomes. These enzymes are primarily used in various sectors including pharmaceutical, animal nutrition, food and beverages, diagnostics, biotechnology, and research. Specialty enzymes are important diagnostic tools for the treatment of diseases such as cancer, lysosomal disorders, and cardiovascular diseases and are also widely used in molecular biology research.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/519
Factors such as rising demand for nutraceuticals, increasing investments in research and development activities, rapid advancements in DNA sequencing, molecular testing, tissue dissociation, and immunological assays, and rising application of specialty enzymes in food and beverages and cosmetic sectors are expected to drive global market growth during the forecast period. However, high initial investments and maintenance costs, lack of regulatory framework, and dearth of skilled professionals to operate advanced systems are some key factors that can hamper overall market growth to a certain extent during the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Microorganisms To Register Robust Revenue Growth:
The microorganisms segment is expected to register robust revenue growth between 2021 and 2028 owing to easy availability, feasibility for large-scale production in low-cost media, and growing demand for various types of microorganisms as valuable resources in medicinal treatment.
Polymerases & Nucleases Segment to Account for Largest Revenue Share:
The polymerases & nucleases segment is expected to account for largest revenue share during the forecast period. This can be attributed to increasing application of polymerases and nucleases across various sectors including pharmaceutical, diagnostics, biocatalysts and research and biotechnology, rapid adoption of genetic testing, and high usage of polymerases and nucleases in nucleic acid processes.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/519
North America to Lead in Terms of Revenue Share:
North America is expected to account for largest revenue share in the global market owing to factors such as presence of large number of biopharmaceutical companies across the region, increasing prevalence of chronic diseases and digestive disorders, and rapid technological advancements. In addition, large consumer base, growing demand for digestive aids and supplements, presence of leading companies, and high focus on developing novel and more effective products are expected to drive North America market growth during the forecast period.
Major Companies in the Market Include:
- Novozymes
- Kerry, Inc.
- Chr. Hansen Holding A/S
- DuPont De Nemours, Inc.
- Associate British Foods Plc
- Specialty Enzymes & Probiotics
- AST Enzymes
- Sanofi
- Amano Enzyme
- Roche Holding
- Dyadic International
- Thermo Fisher Scientific
- Biocatalysts
- Merck KGaA
Scope of Specialty Enzymes Research
| Report Details | Outcome |
| Market size in 2021 | USD 4,565.00 Million |
| CAGR (2022–2030) | 7.0% |
| Revenue forecast to 2030 | USD 8,392.57 Million |
| Base year for estimation | 2021 |
| Historical data | 2019–2020 |
| Forecast period | 2022–2030 |
| Quantitative units | Revenue in USD Million and CAGR in % from 2022 to 2030 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Source, type, form, application and end-user |
| Regional scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Country scope | U.S., Canada, Germany, France, U.K., Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Australia, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, Saudi Arabia, UAE, South Africa, and Rest of MEA |
| Key companies profiled | Novozymes, Kerry, Inc., Chr. Hansen Holding A/S, Dupont De Nemours, Inc., Associate British Foods Plc, Specialty Enzymes & Probiotics., AST Enzymes, Sanofi, Amano Enzyme, Amgen Inc., Roche Holding, Codexis, Dyadic International, Thermo Fisher Scientific, Biocatalysts, and Merck KGaA |
| Customization scope | 10 hours of free customization and expert consultation |
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/specialty-enzymes-market
Emergen Research has segmented global specialty enzymes market on the basis of source, type, form, application, end-use, and region:
Source Outlook (Revenue, USD Million; 2019–2030)
- Microorganisms
- Plants
- Animals
Type Outlook (Revenue, USD Million; 2019–2030)
- Carbohydrases
- Amylases
- Cellulases
- Others
- Proteases
- Lipases
- Polymerases & Nucleases
- Other Enzymes
Form Outlook (Revenue, USD Million; 2019–2030)
- Liquid
- Dry
Application Outlook (Revenue, USD Million; 2019–2030)
- Diagnostic Applications
- Clinical
- Chemistry
- Immunoassay
- Molecular
- Diagnostics
- Other
- Diagnostic
- Pharmaceutical Applications
- Infectious Diseases
- Oncology
- Diabetes
- Neurology
- Other
- Food & Beverages Applications
- Cosmetic Applications
- Others
End Use Outlook (Revenue, USD Million; 2019–2030)
- Pharmaceutical Industries
- Diagnostic Centers
- Food Industries
- Cosmetic Industries
- Others
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/519
Regional Outlook (Revenue, USD Million; 2019–2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Related Published Articles Published by Emergen Research:
Oligonucleotide Synthesis Market
Wastewater Treatment Services Market
Ed-Tech and Smart Classroom Market
Carbon Footprint Management Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available https://www.emergenresearch.com/press-release/global-specialty-enzymes-market